Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Express Scripts
Cerilliant
QuintilesIMS
Moodys
Covington
Teva
Harvard Business School
Fuji

Generated: January 19, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,929,629

« Back to Dashboard

Summary for Patent: 4,929,629
Title: Therapeutic compound
Abstract:N,N-Dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate is a non-hygroscopic material which can be used as a pharmaceutical in the treatment of depression.
Inventor(s): Jeffery; James E. (Nottingham, GB2)
Assignee: Boots Company, PLC (Nottingham, GB2)
Application Number:07/342,638
Patent Claims: 1. An N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate product in crystalline solid form essentially comprising equimolar amounts of N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride and molecularly combined water of hydration, said product exhibiting substantially non-hydroscopic properties when exposed to atmospheric moisture environmental conditions.

2. A pharmaceutical composition comprising an antidepressantly effective amount of the N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate product of claim 1 in combination with a pharmaceutically acceptable diluent or carrier.

3. A method of treating depression in humans which comprises administering to a human in need thereof an antidepressantly effective amount of the composition of claim 2.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Fuji
Chinese Patent Office
Novartis
Julphar
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot